MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.
| Revenue (Most Recent Fiscal Year) | $240.98M |
| Net Income (Most Recent Fiscal Year) | $-1.97M |
| PE Ratio (Current Year Earnings Estimate) | 10.68 |
| PE Ratio (Trailing 12 Months) | 11.05 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.96 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.94 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.05 |
| Pre-Tax Margin (Trailing 12 Months) | 2.47% |
| Net Margin (Trailing 12 Months) | -0.82% |
| Return on Equity (Trailing 12 Months) | 27.51% |
| Return on Assets (Trailing 12 Months) | 9.78% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.63 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.47 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.48 |
| Inventory Turnover (Trailing 12 Months) | 3.13 |
| Book Value per Share (Most Recent Fiscal Quarter) | $29.42 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.65 |
| Earnings per Share (Most Recent Fiscal Year) | $7.54 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.37 |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Common Shares Outstanding | 5.46M |
| Free Float | 5.21M |
| Market Capitalization | $471.46M |
| Average Volume (Last 20 Days) | 0.20M |
| Beta (Past 60 Months) | 0.86 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 90.60% |
| Annual Dividend (Based on Last Quarter) | $0.64 |
| Dividend Yield (Based on Last Quarter) | 0.74% |